-
Ghana artist's billboard campaign takes aim at fast fashion fallout
-
Hopes rise for Iran deal as US halts guiding ships in Hormuz
-
Biogas helps cut bills, deforestation in east DR Congo
-
Protests as Venice Biennale opens in turmoil over Russian presence
-
Zelensky says Russia choosing war as dual ceasefires falter
-
Paris gets taste of Nigeria's Nollywood
-
Simeone, Atletico at crossroads after Arsenal Champions League KO
-
Indonesia eyes e-commerce ban for under-16s: minister to AFP
-
Three evacuated from hantavirus-hit cruise ship
-
US pauses guiding ships through Hormuz, cites Iran deal hopes
-
Venezuela to ICJ: Rights to oil-rich region 'inalienable'
-
Former Russian insider says fear pushed elites to embrace Putin war
-
Evacuations 'ongoing' from hantavirus-hit cruise ship
-
Oil tumbles and stocks rally on peace hopes, Samsung tops $1 trillion
-
Asia football fans sweat on broadcast rights as World Cup nears
-
US pauses Hormuz escorts, Trump says progress on Iran deal
-
Cambodian PM's cousin says owned 30% of scam-linked firm
-
Hegseth's church brings its Christian nationalism to Washington
-
Afrobeats' Tiwa Savage nurtures Africa's future talent
-
Venice Biennale opens in turmoil over Russian presence
-
Philips profits double in first quarter
-
Strasbourg on verge of European final amid fan displeasure at owners BlueCo
-
Tradition, Trump and tennis: Five things about Pope Leo
-
100 years on Earth: Iconic naturalist Attenborough marks century
-
Bondi Beach mass shooting accused faces 19 extra charges
-
Ukraine reports strike as Kyiv's ceasefire due to begin
-
Australia says 13 citizens linked to alleged IS members returning from Syria
-
Thunder overpower Lakers, Pistons down Cavs
-
Boycott-hit 70th Eurovision celebrated under high security
-
Court case challenges New Zealand's 'magical thinking' climate plans
-
Iran war jolts China's well-oiled manufacturing hub
-
Oil sinks and stocks rally on peace hopes, Samsung tops $1 trillion
-
Infantino defends World Cup ticket prices
-
Pistons hold off Cavs to win series-opener
-
Rubio rising? Duel with Vance for 2028 heats up
-
Teen shooter kills two at Brazil school
-
US pauses Hormuz escorts in bid for deal, as threats continue
-
Judge orders German car-ramming suspect to psychiatric hospital
-
Fresh UAE attacks blamed on Iran draw new reality in the Gulf
-
Global Sports Brand U.S. Polo Assn. Delivers Record $2.7 Billion in Retail Sales for 2025, Targets $4 Billion and 1,500 U.S. Polo Assn. Stores
-
Transoft Solutions Acquires CADaptor Solutions
-
Arsenal on cusp of history after reaching Champions League final
-
Trump says pausing Hormuz operation in push for Iran deal
-
Wembanyama accused of 'obvious' illegal blocking
-
Musk 'was going to hit me,' OpenAI executive says at trial
-
NFL star Diggs cleared of assaulting personal chef
-
Fans 'set the standards' at rocking Emirates: Arteta
-
Rahm doesn't see 'many ways out' of multi-year LIV deal
-
Rubio warns against 'destabilizing' acts on Taiwan before Trump China visit
-
US declares Iran offensive over, warns force remains an option
US surgeons report longest successful pig-to-human kidney transplant
US surgeons who transplanted a genetically modified pig kidney into a brain-dead patient announced Thursday they had ended their experiment after a record-breaking 61 days.
The latest experimental procedure is part of a growing field of research aimed at advancing cross-species transplants, mainly testing the technique on bodies that have been donated for science.
There are more than 103,000 people waiting for organ transplants in the United States, 88,000 of whom need kidneys.
"We have learned a great deal throughout these past two months of close observation and analysis, and there is great reason to be hopeful for the future," said Robert Montgomery, director of the New York University Langone Transplant Institute, who led the surgery in July.
It was the the fifth so-called xenotransplant performed by Montgomery, who also carried out the world's first genetically modified pig kidney transplant in September 2021.
Tissue collected during the study indicated a mild rejection process had begun, requiring intensification of immunosuppression medication.
By "knocking out" the gene responsible for a biomolecule called alpha-gal -- a prime target for roving human antibodies -- the NYU Langone team were able to stop immediate rejection.
The donor pig in this experiment came from a herd cultivated by Virginia-based biotech company Revivicor.
The herd has also been approved by the Food and Drug Administration as a source of meat for people with hypersensitivity to the alpha-gal molecule, an allergy caused by some tick bites.
These pigs are bred, not cloned, meaning the process can be more easily scaled.
Early xenotransplantation research focused on harvesting organs from primates -- for example, a baboon heart was transplanted into a newborn known as "Baby Fae" in 1984, but she survived only 20 days.
Current efforts focus on pigs, which are thought to be ideal donors for humans because of their organ size, their rapid growth and large litters, and the fact they are already raised as a food source.
In January 2022, surgeons at the University of Maryland Medical School carried out the world's first pig-to-human transplant on a living patient -- this time involving a heart.
He died two months after the milestone, with the presence of porcine cytomegalovirus in the organ later blamed.
Last week, Chinese scientists published a paper showing they had succeeded in hybrid pig-human kidneys in pig embryos, an alternative approach that also has the potential to one day help address organ donation shortages.
But the development raised ethical issues -- especially since some human cells were also found in the pigs' brains, experts said.
A.Ruegg--VB